MUC16 and ovarian serous tumor: To identify potential mechanisms of changes in CA125 secretion levels in patients with serous ovarian tumors, we conducted a comparison between miRNA sequencing data from tumor tissue (Table S1) and miRWalk data (http://mirwalk.umm.uni-heidelberg.de/ (accessed on 1 February 2023)).